Medtronic plc (MDT)

NYSE: MDT · Real-Time Price · USD
95.92
+0.14 (0.15%)
At close: Oct 20, 2025, 4:00 PM EDT
95.25
-0.67 (-0.70%)
After-hours: Oct 20, 2025, 7:59 PM EDT
0.15%
Market Cap123.04B
Revenue (ttm)34.20B
Net Income (ttm)4.66B
Shares Out 1.28B
EPS (ttm)3.62
PE Ratio26.49
Forward PE16.73
Dividend$2.84 (2.96%)
Ex-Dividend DateSep 26, 2025
Volume5,137,164
Open96.09
Previous Close95.78
Day's Range94.93 - 96.60
52-Week Range79.29 - 99.37
Beta0.79
AnalystsBuy
Price Target104.07 (+8.5%)
Earnings DateNov 18, 2025

About MDT

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair produc... [Read more]

Sector Healthcare
Founded 1949
Employees 95,000
Stock Exchange NYSE
Ticker Symbol MDT
Full Company Profile

Financial Performance

In 2025, Medtronic's revenue was $33.54 billion, an increase of 3.62% compared to the previous year's $32.36 billion. Earnings were $4.66 billion, an increase of 26.82%.

Financial Statements

Analyst Summary

According to 16 analysts, the average rating for MDT stock is "Buy." The 12-month stock price target is $104.07, which is an increase of 8.50% from the latest price.

Price Target
$104.07
(8.50% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Medtronic Stock's $50 Billion Gift To Investors

In the last decade, Medtronic (MDT) stock has returned a notable $52 Bil back to its shareholders through cold, hard cash via dividends and buybacks. Let's look at some numbers and compare how this pa...

7 days ago - Forbes

Medtronic plc - Special Call

Medtronic plc - Special Call Company Participants Ryan Weispfenning - VP & Head of Investor Relations Emily Elswick Conference Call Participants Ryan Zimmerman - BTIG, LLC, Research Division Nathan Tr...

11 days ago - Seeking Alpha

Medtronic BrainSense™ Adaptive Deep Brain Stimulation named a 2025 TIME Best Inventions

TIME Best Inventions honors extraordinary innovations changing lives DUBLIN , Oct. 9, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that Bra...

11 days ago - PRNewsWire

Orchestra BioMed to Showcase Transformative Potential of AVIM Therapy in Keynote Presentation on Hypertensive Heart Disease at Georgia Innovation Summit

Presentation to provide comprehensive overview of AVIM Therapy clinical evidence demonstrating the potential to halt the progression of hypertensive heart disease Orchestra BioMed and Medtronic (NYSE:...

Other symbols: OBIO
11 days ago - GlobeNewsWire

Medtronic initiates U.S. IDE clinical study evaluating Hugo™ robotic-assisted surgery system for gynecological procedures

First procedures completed and enrollment underway in Embrace Gynecology study, furthering the company's progress to expand minimally invasive treatment options to patients in the United States GALWAY...

12 days ago - PRNewsWire

Medtronic Announces Closing of Public Offering of €1.5 Billion of Senior Notes

GALWAY, Ireland , Sept. 29, 2025 /PRNewswire/ -- Medtronic plc (the "Company") (NYSE: MDT) announced today that its wholly-owned indirect subsidiary, Medtronic, Inc., has closed a registered public of...

21 days ago - PRNewsWire

Medtronic: FY26 Outlook Strengthened By New Product Launches

Medtronic (MDT) is undervalued, with strong organic growth and an 11% upside to a $105 target price, supporting a Buy rating. MDT's innovation pipeline, portfolio transformation, and spin-off of the d...

25 days ago - Seeking Alpha

Medtronic plc (MDT) Presents at Bank of America Global Healthcare Conference 2025 Transcript

Medtronic plc (NYSE:MDT) Bank of America Global Healthcare Conference 2025 September 24, 2025 9:10 AM EDT Company Participants Thierry Pieton - Executive VP & CFO Presentation Unknown Analyst We're g...

26 days ago - Seeking Alpha

Medtronic secures FDA approval for the Altaviva™ device, a simple experience for treating urge urinary incontinence

The Implantable Tibial Neuromodulation (ITNM) device will expand treatment options for the 16 million people living with urinary urges and involuntary leaks GALWAY, Ireland , Sept. 19, 2025 /PRNewswir...

4 weeks ago - PRNewsWire

Medtronic: Buy This Dividend Aristocrat While It's Good Value

Medtronic remains a Buy for long-term investors, offering steady growth, durable income, and an attractive valuation below historical averages. MDT delivered solid fiscal Q1 2026 results, with 8.4% re...

4 weeks ago - Seeking Alpha

Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 3% Dividend Yields

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...

Other symbols: ABBVPINC
4 weeks ago - Benzinga

Medtronic Announces Pricing of €1.5 Billion of Senior Notes

GALWAY, Ireland , Sept. 15, 2025 /PRNewswire/ -- Medtronic plc (the "Company") (NYSE: MDT) announced today that its wholly-owned indirect subsidiary, Medtronic, Inc., has priced an offering (the "Offe...

5 weeks ago - PRNewsWire

Medtronic initiates global pivotal study of cardiac pacing in a new patient population

Study to evaluate whether a new approach to pacing the heart can improve the lives of patients with heart failure with preserved ejection fraction (HFpEF) who have limited treatment options today GALW...

5 weeks ago - PRNewsWire

Medtronic Plc (MDT) Presents At Deutsche Bank Healthcare Summit Transcript

Medtronic plc (NYSE:MDT) Deutsche Bank Healthcare Summit September 10, 2025 12:00 PM EDT Company Participants Conference Call Participants Pito Chickering - Deutsche Bank AG, Research Division Presen...

5 weeks ago - Seeking Alpha

Medtronic Plc (MDT) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Medtronic plc (NYSE:MDT) Morgan Stanley 23rd Annual Global Healthcare Conference September 8, 2025 4:50 PM EDT Company Participants Thierry Pieton - Executive VP & CFO Conference Call Participants Pa...

6 weeks ago - Seeking Alpha

Medtronic Plc (MDT) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 (Transcript)

Medtronic plc (NYSE:MDT) Wells Fargo 20th Annual Healthcare Conference 2025 September 4, 2025 8:00 AM EDT Company Participants Geoffrey Martha - Chairman of the Board & CEO Thierry Pieton - Executive...

6 weeks ago - Seeking Alpha

Study of Medtronic Hugo™ robotic-assisted surgery system in hernia repair meets safety and effectiveness endpoints

First-ever investigational device exemption clinical study for robotic-assisted hernia repair in the U.S. presented at the American Hernia Society annual meeting GALWAY, Ireland and NASHVILLE, Tenn. ,...

6 weeks ago - PRNewsWire

FDA Clears MiniMed™ 780G System to Enable Integration with the Instinct Sensor, Made by Abbott, and Approves Use in Type 2 Diabetes

GALWAY, Ireland , Sept. 2, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced two U.S. Food and Drug Administration (FDA) regulatory milestones t...

6 weeks ago - PRNewsWire

Medtronic executives to speak at upcoming investor conferences

GALWAY, Ireland , Aug. 29, 2025 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it will participate in the following investor conferences: 2025 Well...

7 weeks ago - PRNewsWire

Why Medtronic Has Been Stuck for Over 1,100 Days And What Lies Ahead

Medtronic MDT has been trapped in a tight consolidation band for what feels like forever. For more than 1,100 days, the stock has stubbornly stayed between $75 and $95, showing little sign of life.

7 weeks ago - Benzinga

Best Dividend Aristocrats For September 2025

Dividend Aristocrats have shown mixed 2025 performance, with some delivering double-digit gains and others lagging, but overall stability remains a hallmark. Dividend growth is robust, with 53 of 69 A...

7 weeks ago - Seeking Alpha

Medtronic makes two key additions to its board. How activist Elliott can build shareholder value

The stage seems to be set for a long-term mutually beneficial relationship between the parties.

2 months ago - CNBC

Medtronic: Earnings Are Solid, New Board Additions Add Intrigue

Medtronic delivered solid earnings, with standout growth in Cardiovascular, but overall performance remains mixed due to weaker Neuroscience and MedSurg segments. Elliott Management's activist involve...

2 months ago - Seeking Alpha

Medtronic Has Potential To Pursue Further Divestitures: Analyst

On Tuesday, Medtronic Plc MDT reported second-quarter earnings and announced key board appointments after Elliott Investment Management became the company's largest shareholder.

2 months ago - Benzinga

These Analysts Boost Their Forecasts On Medtronic After Upbeat Q1 Earnings

Medtronic plc MDT posted better-than-expected earnings for the first quarter and announced key board appointments on Tuesday, naming John Groetelaars and Bill Jellison as independent directors, effect...

2 months ago - Benzinga